MYLAN-ABACAVIR/LAMIVUDINE
MYLAN-ABACAVIR/LAMIVUDINE
Approved
DIN Number
02450682
Drug Class
Human
Market Date
Mar 29, 2016
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02450682
AIG Number0251241001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR02 LAMIVUDINE AND ABACAVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification
ACTIVE INGREDIENTS (2)
ABACAVIR (ABACAVIR SULFATE)Active
Strength: 600 MG
Monograph: ABACAVIR (ABACAVIR SULFATE)
LAMIVUDINEActive
Strength: 300 MG
Monograph: LAMIVUDINE